Sign in

CIK 0000885590

  • Large accelerated filer

Bausch Health Companies Inc.

Sign in to watch
Ticker
BHC
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NJ
Entity type
Operating
Phone
+1 514-744-6792
Business address
2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
Former names
Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
  1. 4 Grant or award Pres&Co-Head Bausch&Lomb/Int'l acquired 90,260 shares (grant or award)
  2. 4 Shares withheld for taxes President, Salix gave up 1,278 shares (to pay taxes)
  3. 4 Shares withheld for taxes EVP AND GENERAL COUNSEL gave up 5,017 shares (to pay taxes)
  4. 4 Open-market buy Director bought 1,400 shares at $25.94 ($36,316)
  5. 4 Open-market buy Director bought 10,000 shares at $25.01 ($250,123)
  6. 4 Grant or award Director acquired 234 shares (grant or award)
  7. 4 Grant or award Director acquired 1,300 shares (grant or award)
  8. 4 Grant or award Director acquired 1,044 shares (grant or award)
  9. 4 Grant or award Director acquired 1,044 shares (grant or award)
  10. 4 Grant or award Director acquired 1,044 shares (grant or award)
  11. 4 Grant or award Director acquired 1,172 shares (grant or award)
  12. 4 Open-market sale EVP & Chief Financial Officer sold 17,000 shares at $31.68 ($538,586)
  13. 4 Open-market sale EVP AND GENERAL COUNSEL sold 121,198 shares at $31.83 ($3,857,732)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Grant or award EVP & Chief Financial Officer acquired 33,673 shares (grant or award)
  16. 4 Open-market sale Director sold 11,037 shares at $31.79 ($350,811)
  17. 4 Grant or award Director acquired 7,645 shares (grant or award)
  18. 4 Grant or award Director acquired 7,645 shares (grant or award)
  19. 4 Grant or award Director acquired 7,645 shares (grant or award)
  20. 4 Grant or award Director acquired 7,645 shares (grant or award)

Page 14 of 61 · 1,214 filings